I worked in metabolic disease drug discovery in the pharmaceutical industry for more than 22 years. (science.sciencemag.org)
I prefer infectious disease drug discovery and / or development but would also consider other areas. (members.climber.com)
Our Rare Disease Drug Development Model Cydan is focused on accelerating meaningful therapies for people with rare monogenic, non-oncologic diseases. (cydanco.com)